Imagion Biosystems Ltd. (AU:IBX) has released an update.
Imagion Biosystems Ltd. has announced a significant change in the interests of its director, Brett Mitchell, with the acquisition of 3.75 million ordinary shares and 1.875 million unlisted options. The transaction, valued at $75,000 for the shares, reflects a strategic move by Mitchell, potentially indicating confidence in the company’s future growth.
For further insights into AU:IBX stock, check out TipRanks’ Stock Analysis page.